Tue, Jan 21 · 8:00

1. Discuss strategy development to implement new tools in the clinical trial setting

2. Look at the design, execution, and operation of clinical trials

3. Move beyond the clinical pilots to plan for success and scalability

4. Review current trends of trial management and how to move forward with these changes

5. Learn how to adapt to new quality trends that are impacting clinical development

Brochure: https://go.evvnt.com/529318-3?pid=5731

Pharma/Biotech- Early Bird (2-Day Conference Access) : USD 1295.0,
Service Provider- Early Bird(2-Day Conference Access) : USD 1695.0,
Pharma/Biotech-Standard : USD 1495.0,
Service Provider-Standard : USD 1895.0,
Pharma/Biotech- Onsite : USD 1695.0,
Service Provider-Onsite : USD 2095.0,
Add-On Full Day Seminar (1/21) : USD 495.0

Speakers: Caryn Barnett- Endocyte, Liza Brienza- Merck, Kathie Clark- Ennov, Deborah Collyar- Patient Advocates In Research (PAIR), Debbie Cote- Coherus BioSciences, Mary Elmer- Merck, Betsy Fallen-SAFE-Biopharma Association, Ran Frenkel- Karyopharm Therapeutics, Kenneth Getz- TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT; CISCRP, Camisha Harge- Coherus BioSciences, Ram Josyula- Bristol-Myers Squibb, Mitchell Katz- Ferring Pharmaceuticals, Aryn Knight, B.S.,- CCRP TEXAS HEART INSTITUTE, Jim Kremidas- Association of Clinical Research Professionals (ACRP), Craig Lipset- Pfizer, Amy Lounsbury- Minnesota Gastroenterology P.A. Inc, Brigid McTague- Janssen, Matthew Michela- Life Image, David Morin- Holston Medical Group, Amy Neubauer- Alkermes, Catina O'Leary- Health Literacy Media (HLM), Rich Polgar- Bristol-Myers Squibb, Debbie Profit- Otsuka, Christine Sawicki- CVS Health, Dr. Kelly Shanahan- Patient Advocate, Panna Sharma- Lantern Pharma, Michael Song- AstraZeneca, Denise Steckel- Genentech, Patrick Zbyszewski- Onconova